Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5496 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 ... 53 54 55  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Modag–SEVERAL: investment, 201906 financing round Series A €12m led by Massa Investment AG 2019-06-27
Modag–Trophic Communications: public relations, 201906 service existent by Trophic 2019-06-27
PhagoMed–SEVERAL: investment, 201906 2nd financing round €1.5m from existing + new investors 2019-06-27
Velabs Therapeutics–SEVERAL: investment, 201906 financing round Series B €3m 2019-06-27
Evotec–SEVERAL: credit, 201906– promissory note €250m with lead arrangers Deutsche Bank + LBBW 2019-06-26
Allergan–AbbVie: investment, 201905– acquisition $63b in cash + shares by AbbVie ANNOUNCED 2019-06-25
Vesalius Biocapital–SEVERAL: investment, 201906 final closing of €120m Vesalius Biocapital III fund 2019-06-25
Avacta–JSR Corp: cell line development, 201906– CHO cell line development for clinical manufacturing of AVA004 Affimer PD-L1 antagonist by Selexis 2019-06-20
Gamida Cell–Lonza: cell therapy contract manufacturing, 201906– supply multi-year future commercial production of omidubicel by Lonza in Geleen (NL) 2019-06-19
Germany (govt)–Trophic Communications: public relations, 201906 service existent for German Accelerator Life Sciences by Trophic 2019-06-18
Merck (DE)–SEVERAL: credit, 201906 hybrid €1.5b bond to finance acquisition of Versum Materials Inc 2019-06-18
ADC Therapeutics–SEVERAL: investment, 201906–201907 financing round Series E expansion $103m bringing total Series E to $303m 2019-06-12
Ipsen–Debiopharm: triptorelin, 201906– strategic collab extension 15y developm + prod + distrib Decapeptyl in Europe + certain Asia + Africa 2019-06-12
4SC–SEVERAL: investment, 201906 capital increase €11m with 4.677m new shares at €2.37/share 2019-06-11
Binding Site–Tecan: laboratory automation, 201906 collab existent developm automated solution for using MALDI-MS to diagnose blood cancers 2019-06-06
HighChem–Thermo Fisher: investment, 201906 acquisition €na of HighChem Ltd by Thermo Fisher 2019-06-06
Merck (DE)–Rigaku: X-ray crystallography, 201906– collab developm of devices for use with Merck consumables using crystalline sponge technology 2019-06-06
Merck (DE)–Univ Tokyo: crystalline sponge technology, 201906– license for technolgoy invented by Prof Makoto Fujita 2019-06-06
Vertex–CRISPR Therapeutics: CRISPR technology, 201906– collab expansion $175m upfront + $825m milestones CRISPR for DMD + DM1 gene editing products 2019-06-06
MiniFab–Schott: investment, 201906– acquisition of MiniFab Pty Ltd by Schott 2019-06-05
Agilent–Frost & Sullivan: market research, 201906 supply service survey of pharma lab leaders on lab workflows by F&S 2019-06-04
Arvinas–Bayer: investment, 201906 direct equity investment in Arvinas Inc as part of collab in protein degradation drugs using PROTAC technology 2019-06-04
Bayer–Arvinas: protein degradation drugs, 201906– collab up to $745m developm of drug candidates using PROTAC technology 2019-06-04
Spindiag–SEVERAL: investment, 201906 financing round Series A exansion additional €4m incl new investor WBG Pflegeheime 2019-06-04
Yukin Therapeutics–SEVERAL: investment, 201906 financing round €3.3m co-led by Advent France Biotechnology + Medicxi 2019-06-04
Bruker–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems 2019-06-03
Otsuka–LeadXPro: structure-based drug discovery, 201906– collab strategic on membrane protein structure research of Astex + LeadXPro 2019-06-03
Bruker–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data 2019-05-31
Bruker–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Helmholtz–Bruker: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Medical Univ South Carolina–Bruker: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC 2019-05-31
BlueHaven Therapeutics–MC Services: public relations, 201905 service existent IR by MC Services 2019-05-30
Bayer–Roche: molecular companion diagnostics, 201905– collab ww €na developm + commercialisation o fNGS-based CDx in oncology 2019-05-29
PHW-Gruppe–Ampersand: investment, 201905 acquisition of Vibalogics GmbH by Ampersand Capital Partners 2019-05-29
Biocrates–NONE: investment, 201905– bankruptcy filed for subsidiary Metanomics Health GmbH 2019-05-22
Cubuslab–Labfolder: investment, 201905 acquisition merger of Cubuslab Gmbh + Labfolder GmbH + new name Labforward GmbH 2019-05-22
JnJ–Owlstone: breath analyser, 201905– collab developm breath-based test for early detection of pulmonary hypertension with Actelion 2019-05-20
Just Biotherapeutics (US)–Evotec: investment, 201905–201907 acquisition 100% for $60m upfront + $30m upfront 2019-05-20
Storm Therapeutics–Merck (DE): investment, 201905 financing round Series A extension totalling £14m incl existing investor M Ventures 2019-05-20
Storm Therapeutics–SEVERAL: investment, 201905 financing round Series A extension £14m bringing total round to £30m incl new investor Seroba LS 2019-05-20
LabCentral–Harrison Street: business park, 201905 supply service existent LabCentral is anchor tenant at Osborn Triangle lab complex in Cambridge MA 2019-05-17
MIT–Harrison Street: business park, 201905 acquisition of Osborn Triangle complex by Harrision Street + Bulfinch from MIT with MIT retaining interest 2019-05-17
Novartis–Harrison Street: business park, 201905 supply service existent Novartis 1 of 3 anchor tenants at Osborn Triangle lab complex in Cambridge MA 2019-05-17
DNA Script–Life Sciences Partners: investment, 201905 financing round Series B totalling $38.5m incl new + lead investor LSP 2019-05-16
DNA Script–SEVERAL: investment, 201905 financing round Series B $38.5m led by LSP 2019-05-16
Inovio–Qiagen: molecular companion diagnostics, 201905– collab developm of CDx for VGX-3100 DNA-based immunotherapy for cervical dysplasia 2019-05-16
Roche–AbbVie: ventoclax, 201905 collab existent joint commercialisation in US as Venclexta by AbbVie + Genentech 2019-05-16
Navan Technologies–High-Tech Gründerfonds: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
Navan Technologies–SEVERAL: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
Navan Technologies–Stanford Univ: cell therapy technology, 201905 license excl existent to NanoStraw technology platform 2019-05-15
Novartis–Codexis: protein engineering technology, 201905– tech transfer + license agreem for CodeEvolver technology to be installed at a Novartis site 2019-05-15
Vaccitech–Minapharm: cell line, 201905– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines 2019-05-15
Icometrix–Bertarelli Group: investment, 201905 financing round totalling $18m incl new + lead investor Forestay Capital 2019-05-14
Icometrix–Capricorn Venture Partners: investment, 201905 financing round totalling $18m incl existing + co-investor Capricorn Venture Partners 2019-05-14
Icometrix–Optum Ventures: investment, 201905 financing round totalling $18m incl new + co-investor Optum Ventures 2019-05-14
Icometrix–SEVERAL: investment, 201905 financing round $18m led by Forestay Capital + incl Optum Ventures + Capricorn Venture Partners 2019-05-14
Philogen–Consilium: public relations, 201905 service existent by CSC 2019-05-13
Philogen–SEVERAL: investment, 201905 financing round €62m from existing + new private investors 2019-05-13
TreeFrog Therapeutics–SEVERAL: investment, 201905 financing round Series A €6.5m led by XAnge + incl Galia Geston et al 2019-05-13
Priavoid–PERSON: investment, 201905c Detlev Riesner recently acquired shares of Priavoid GmbH 2019-05-10
MabVax Therapeutics–BioNTech: investment, 201905 acquisition €na of antibody assets + infrastructure + lab equipment in San Diego 2019-05-08
Therachon–Cowen: investment, 201905 existing investor Cowen 2019-05-08
Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative 2019-05-08
Therachon–Novo Group: investment, 201905 existing investor Novo Holdings 2019-05-08
Therachon–OrbiMed: investment, 201905 existing investor OrbiMed 2019-05-08
Therachon–Pfizer: investment, 201905 existing investor Pfizer Ventures 2019-05-08
Therachon–Pfizer: investment, 201905– acquisition 100% $340m upfront + $470m milestones excl apraglutide development program 2019-05-08
Therachon–Tekla Capital: investment, 201905 existing investor Tekla Capital Management LLC 2019-05-08
Therachon–Versant Ventures: investment, 201905 existing investor Versant Ventures 2019-05-08
Confo Therapeutics–SEVERAL: investment, 201905 financing round Series A €30m led by BGV + co-led by Wellington Partners 2019-05-07
Confo Therapeutics–Wellington Partners: investment, 201905 financing round Series A totalling €30m incl new + co-lead investor Wellington Partners 2019-05-07
DyNAbind–High-Tech Gründerfonds: investment, 201905 seed financing round incl new investor HTGF 2019-05-07
DyNAbind–Saxony (govt): investment, 201905 seed financing round incl new investor Technologiegründerfonds Sachsen 2019-05-07
DyNAbind–SEVERAL: investment, 201905 seed financing round from HTGF + TGFS + TUDAG 2019-05-07
DyNAbind–TU Dresden: investment, 201905 seed financing round incl existing investor TUDAG TU Dresden AG 2019-05-07
Merck (DE)–DyNAbind: drug discovery technology, 201905 collab existent marketing of DEL discovery kit with Merck KGaA 2019-05-07
Northwestern Univ–DyNAbind: drug discovery technology, 201905 collab existent with Northwestern Univ Chicago 2019-05-07
OMass–DyNAbind: drug discovery technology, 201905 collab existent with OMass Therapeutics 2019-05-07
Sosei–DyNAbind: drug discovery technology, 201905 collab existent with Sosei Heptares 2019-05-07
Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise 2019-05-06
Intermolecular–Merck (DE): investment, 201905– acquisition of Intermolecular Inc by Merck for $62m in cash at $1.2/share 2019-05-06
Chemical Solutions Ltd–SGS: investment, 201905 acquisition of CSL by SGS 2019-05-03
Amal Therapeutics–Boehringer: cancer drugs, 201905– collab clinical research combi study of ATP128 + BI754091 in colorectal cancer 2019-05-02
CStone–Numab: antibody cancer drug, 201905– collab + license for tri-specific antibody ND021 in Greater China + KR + SG 2019-05-02
miRdetect–Bremen (govt): investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–High-Tech Gründerfonds: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–OTHER: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–SEVERAL: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
Alentis Therapeutics–Bellevue: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BB Pureos Bioventures 2019-04-30
Alentis Therapeutics–BioMedPartners: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BioMedPartners 2019-04-30
Alentis Therapeutics–France (govt): investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Bpifrance 2019-04-30
Alentis Therapeutics–High-Tech Gründerfonds: investment, 201904 financing round Series A totalling CHF12.5m incl co-investor HTGF 2019-04-30
Alentis Therapeutics–Instinctif Partners: public relations, 201904 service existent media relations by Instinctif 2019-04-30
Alentis Therapeutics–Schroders: investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Schroder Adveq 2019-04-30
Alentis Therapeutics–SEVERAL: investment, 201904 financing round Series A CHF12.5m co-led by BioMedPartners + BB Pureos Bioventures 2019-04-30
SGS–Veeva Systems: clinical research software, 201904– supply global implementation of Veeva Vault CTMS by SGS 2019-04-30
Canopy Biosciences–Ampersand: investment, 201904 strategic growth investment from Ampersand Capital Partners 2019-04-29
Zellkraftwerk–Canopy Biosciences: investment, 201904 acquisition of Zellkraftwerk GmbH by Canopy Biosciences 2019-04-29
ADC Therapeutics–Adagene: antibody technology, 201904– collab + license agreem €na using SAFEbody technology for ADC development 2019-04-24
Chiome Bioscience–Velabs Therapeutics: antibody drug discovery, 201904– collab using Velabs’ microfluidcs techn for functional antibody screening 2019-04-24
next pagenext page 1 2 3 4 5 ... 53 54 55  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top